Cytoplasmic RNA viruses as potential vehicles for the delivery of therapeutic small RNAs

ABSTRACT: Viral vectors have become the best option for the delivery of therapeutic genes in conventional and RNA interference-based gene therapies. The current viral vectors for the delivery of small regulatory RNAs are based on DNA viruses and retroviruses/lentiviruses. Cytoplasmic RNA viruses hav...

Full description

Autores:
Usme Ciro, José Aldemar
Campillo Pedroza, Natalia
Almazán, Fernando
Gallego Gómez, Juan Carlos
Tipo de recurso:
Review article
Fecha de publicación:
2013
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/41437
Acceso en línea:
https://hdl.handle.net/10495/41437
Palabra clave:
Virus ARN
RNA Viruses
MicroARNs
MicroRNAs
Terapia Genética
Genetic Therapy
Citoplasma
Cytoplasm
Portadores de Fármacos
Drug Carriers
Vectores Genéticos
Genetic Vectors
Interferencia de ARN
RNA Interference
ARN Pequeño no Traducido
RNA, Small Untranslated
https://id.nlm.nih.gov/mesh/D012328
https://id.nlm.nih.gov/mesh/D035683
https://id.nlm.nih.gov/mesh/D015316
https://id.nlm.nih.gov/mesh/D003593
https://id.nlm.nih.gov/mesh/D004337
https://id.nlm.nih.gov/mesh/D005822
https://id.nlm.nih.gov/mesh/D034622
https://id.nlm.nih.gov/mesh/D058727
Rights
openAccess
License
https://creativecommons.org/licenses/by/4.0/
Description
Summary:ABSTRACT: Viral vectors have become the best option for the delivery of therapeutic genes in conventional and RNA interference-based gene therapies. The current viral vectors for the delivery of small regulatory RNAs are based on DNA viruses and retroviruses/lentiviruses. Cytoplasmic RNA viruses have been excluded as viral vectors for RNAi therapy because of the nuclear localization of the microprocessor complex and the potential degradation of the viral RNA genome during the excision of any virus-encoded pre-microRNAs. However, in the last few years, the presence of several species of small RNAs (e.g., virus-derived small interfering RNAs, virus-derived short RNAs, and unusually small RNAs) in animals and cell cultures that are infected with cytoplasmic RNA viruses has suggested the existence of a non-canonical mechanism of microRNA biogenesis. Several studies have been conducted on the tickborne encephalitis virus and on the Sindbis virus in which microRNA precursors were artificially incorporated and demonstrated the production of mature microRNAs. The ability of these viruses to recruit Drosha to the cytoplasm during infection resulted in the efficient processing of virus-encoded microRNA without the viral genome entering the nucleus. In this review, we discuss the relevance of these findings with an emphasis on the potential use of cytoplasmic RNA viruses as vehicles for the efficient delivery of therapeutic small RNAs